As reported by Aunt Minnie on January 18, 2013, PET/CT with a combination of the tracers carbon-11 (C-11) acetate and FDG was significantly less affected by cirrhotic changes, according to the researchers, and it outperformed contrast-enhanced CT in HCC lesion detection and tumor staging among liver transplant patients, as well as in cases of partial hepatectomy.